Research ArticleOpen Access
ESBL/Cephalosporinase-producing Escherichia coli from retail poultry meat in Tunisia: Predominance of blaCTX-M gene and multidrug resistance
1Université de Tunis El Manar, Institut de la recherche vétérinaire de Tunisie, Bab Saadoun, 1006 Tunis, Tunisie
2Université de Tunis El Manar, Faculté de Médecine de Tunis, laboratoire de résistance aux antibiotiques LR99ES09, Tunis, Tunisie
3OTD Centre avicole de Mateur, Bizerte, Tunisie
|Abbassi Mohamed Salah|
|Institute of Veterinary Research of Tunisia|
|20 Street Jebel Lakhdhar|
|Bab Saadoun, Tunis 1006, Tunisia|
|Tel: 00216 71 561 070|
|Fax: 00216 71 569 692|
Received: May 15, 2017; Published: July 17, 2017
Citation: Abbassi Mohamed Salah (2017) ESBL/Cephalosporinase-producing Escherichia coli from retail poultry meat in Tunisia: Predominance of blaCTX-M gene and multidrug resistance. J Microbes Microbio Techni 1(1): 102
In the present study, 80 samples of chicken meat collected from various super markets in Tunis City, Tunisia, were analyzed for detection of ESBL-, pAmpC-producing E. Coli. Thirteen cefotaxime resistant E. Coli isolates were recovered. The majority of these isolates were resistant to amoxicillin, amoxicillin/clavulanic acid, ceftazidime and cefotaxime and a positive synergy was detected in 23 isolates, however, resistance to imipenem was not observed. The majority of these isolates were multidrug-resistant (tetracycline, streptomycin, trimethoprim / sulfamethoxazole). According to PCR investigating of bla genes (blaCTX-M, blaTEM, blaSHV), blaCTX-M gene was detected in 27 isolates, 4 out them contained the blaTEM gene, and one co-harbored the blaSHV gene. One isolate contained only the blaTEM gene. Two isolates did not show any of the investigated genes. These finding suggest that raw chicken retail meats are highly contaminated with ESBL-producing E. Coli implementing a great risk to human health in Tunisia.
Keywords: Retail Chicken Meat; E. Coli; Esbl; Multi-Drug Resistance
Plasmid-mediated beta-lactamases (extended spectrum beta-lactamases (ESBLs) and AmpC β-lactamases (pAmpC)) have been of great concern worldwide. The rapid increase in the proportion of ESBL-producing E. Coli in alimentary tract of food producing and pet animals have been occurred globally since 2000s . Therefore, prevalence of ESBL-producing E. Coli has been also appeared to be in increase in various foodstuffs including raw milk, dairy products and meat, particularly chicken meat . Retail chicken meat contaminated by E. Coli producing ESBLs or pAmpC has been increasingly reported worldwide [3,4]. Many reports have described the close genetic relatedness of E. Coli isolates of animal and human origins. Such transmission (animal to human) is likely occurred by physic contacts or by consummation of food products containing resistant E. Coli isolates. This phenomenon likely contributes to the increased incidence of infections with these bacteria in humans [2,5]. The aims of this study were investigate the occurrence of ESBL/cephalosporinase-producing E. Coli in retail chicken meat in Tunisia and to investigate ESBL- encoding genes in the collected isolates.
A total of 80 poultry meat were purchased from three local markets in Tunis City, Tunisia, from January to April 2016. For bacterial isolation, 25 g of each sample was inoculated into 225 mL of buffered peptone water and incubated at 37 °C for 18 h. One milliliter of each culture was then inoculated on Tryptone-Bile-Glucuronic Agar (TBX Agar) (HiMedia Laboratories) containing 2 mg/L cefotaxime and cultured at 37 °C for 24 h. From each plate, one colony with typical morphology of E. Coli was selected and identified by Api20E (Bio-Mérieux, France).
The antimicrobial susceptibility of bacterial isolates was determined using the agar diffusion method according to the Clinical and Laboratory Standards Institute . E. Coli ATCC 25922 was used for quality control. Isolates were screened for the ESBL-producing phenotype by the standard double-disc synergy test, as described previously . The following antimicrobial discs (Oxoid) were used: amoxicillin/clavulananic acid (30/10 μg), cefotaxime (30 μg), cefepime (30 μg), ceftazidime (30 μg) and aztrenam (30 μg). For quality control, Klebsiella pneumoniae ATCC 700603) was used.
Bacterial DNA was extracted by boiling 3 to 5 colonies in 500 μL of sterile water during 10 min. The extracted DNA was used as the template for PCR amplification of blaTEM, blaSHV and blaCTX-M genes encoding the most common ESBL enzymes as previously reported [8,9]. Gel electrophoresis was used for the analysis of PCR products using 2 % agarose gel and ethidium bromide (0.5 μg/mL) staining.
In Tunisia and worldwide, livestock have been recognized as important reservoir of antibiotic-resistant zoonotic bacteria such as methicillin-resistant Staphylococcus aureus, ESBL-producing Enterobacteriaceae (mainly E. Coli) and vancomycin-resistant enterococci . Resistant bacteria are transferred to human via food chain or direct contact with animals. In our work, 30 (37.5 %) out of the 80 samples of chicken meat contained cefotaxime-resistant E. Coli isolates (Table 1). This prevalence for carriage of cefotaxime-resistant E. Coli is compared to other ones reported worldwide, highlighting the importance of poultry and poultry meat as reservoir of extended-sprectrum cephalosporin-resistant E. Coli [11,12]. A positive synergy test was observed in 23 isolates, and therefore was classified as ESBL producers. The remaining 7 isolates were resistant to amoxicillin, amoxicillin-clavulanic acid, ceftazidim, cefotaxime and cefoxitine. This phenotype is typical to cephalosporinase production; however, this do not means that these isolates are not ESBL producers. Indeed, co-production of ESBLs and plasmidic cephalosporinases is common in E. Coli from human and animal origins [3,11]. Antibiotic susceptibility showed that the majority of isolates were multidrug resistant, being resistant not only to beta-lactams but also to nalidixic acid, ciprofloxacin, tetracycline, streptomycin, and trimethoprim / sulfamethoxazole. This multiresistance trait has been increasingly reported in E. Coli from poultry and poultry meat worldwide as well as in Tunisia [13,14]. It seems that for infections caused by such multi-drug resistant E. Coli isolates, therapeutic options are limited and might be restricted to aminosides (gentamicin, amilakacin) and to imipenem (all our isolates were susceptible to these antibiotics). According to PCR investigating of commonly reported bla genes (blaCTX-M, blaTEM, blaSHV), the blaCTX-M gene was detected in 27 isolates, 4 out them contained the blaTEM gene, and one co-harbored the blaSHV gene. In addition one isolate contained only the blaTEM gene; however, two isolates with negative synergy test harbored none of these genes (Table 1). Unfortunately, Owing to many financial limitations we were unable to sequence these genes in order to know the exact variants of these genes. However, according to the epidemiology of avian ESBL-producing E. Coli isolates, we can speculate the occurrence of blaCTX-M-1 in our isolates [13-15]. The epidemiology of genes encoding ESBLs has changed dramatically by the beginning of the 20st centry. Indeed, during the last 17 years ESBLs encoded by the classical TEM- and SHV-ESBLs have increasingly decreased to give way to CTX-M- enzymes. Currently, CTX-M enzymes are pandemic and were identified from patients, healthy humans, livestock, companion animals, food products and sewage . Three isolates harbored the blaCTX-M and one harbored the blaTEM were cephalosporinase producers par the synergy test; it seems that these isolates harbored also a plasmidic AmpC cephalosporinase enzyme such as blaCMY-2 as reported previously . In conclusion, our results showed high prevalence of ESBL/cephalosporinase-producing E. Coli isolates from retail chicken meat. Isolates were multi-drug resistant, and the majority harbored a blaCTX-M gene and some of them most likely co-harbored a plasmidic AmpC gene. The spread of such isolates in the environment and to Human is worrisome, since therapeutic options against them are limited.
|Isolates||Antibiotic resistance profiles*||Synergy test||Genes|
|Ec.1||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.2||NAL, CIP, SXT, TET, S, AMX, AMC, FOX, CAZ, CTX||-||CTX-M|
|Ec.3||NAL, CIP, SXT, TET, AMX, AMC, FOX, CAZ, CTX||-||CTX-M|
|Ec.4||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.5||NAL, CIP, SXT, TET, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.6||NAL, CIP, SXT, TET, AMX, AMC, FOX, CAZ, CTX||-||-|
|Ec.7||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M+SHV|
|Ec.8||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.9||NAL, CIP, SXT, TET, S, CO, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.10||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX.||+||CTX-M|
|Ec.11||NAL, CIP, SXT, TET, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.12||NAL, CIP, SXT, TET, AMX, AMC, FOX, CAZ, CTX||-||CTX-M|
|Ec.13||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.14||NAL, CIP, SXT, TET, AMX, AMC, FOX, CAZ, CTX||-||CTX-M|
|Ec.15||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.16||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M|
|Ec.17||NAL, CIP, SXT, TET, AMX, AMC, FOX, CAZ, CTX||-||-|
|Ec.18||NAL, CIP, CO, AMX, AMC, CTX||+||CTX-M|
|Ec.19||NAL, CIP, SXT, TET, S, AMX, AMC, CAZ, CTX||+||CTX-M+TEM|
|Ec.20||NAL, CIP, SXT, TET, S, AMX, FOX, CAZ, CTX||+||CTX-M|
|Ec.21||NAL, CIP, SXT, TET, S, CO,AMX, AMC, FOX, CAZ, CTX||-||TEM|
|Ec.22||NAL, CIP, SXT, TET, S, CO, AMX, CAZ, CTX||+||CTX-M|
|Ec.23||NAL, CIP, SXT, TET, S, AMX, CAZ, CTX||+||CTX-M|
|Ec.24||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M +TEM|
|Ec.25||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M +TEM|
|Ec.26||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M +TEM|
|Ec.27||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M|
|Ec.28||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M|
|Ec.29||SXT, TET, S, AMX, CAZ, CTX||+||CTX-M|
|Ec.30||SXT, TET, AMX, CAZ, CTX||+||CTX-M|
*NAL: nalidixic acid, CIP: ciprofloxacin, SXT : trimethoprim / sulfamethoxazole, TET : tetracycline, S: streptomycin, CO: colistin, AMX: amoxicillin, AMC: amoxicillin-clavulanic acid, FOX : cefoxitin, CAZ : ceftazidime, CTX : cefotaxime
Table 1: Characteristics of cefotaxime-resistant E. Coli isolates
- 1. Aarestrup FM, Hasman H, Agersø Y, Jensen LB, Harksen S, Svensmark B (2006) First description of blaCTX-M-1-carrying Escherichia coli isolates in Danish primary food production. J Antimicrob Chemother. 57(6):1258-9.
- 2. Alonso CA, Zarazaga M, Ben Sallem R, Jouini A and Ben Slama K (2017) Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective. Lett Appl Microbiol. 64(5):318-334.
- 3. Priyanka Bajaj, Nambram S. Singh, and Jugsharan S. Virdi (2016) Escherichia coli β-Lactamases: What Really Matters Front Microbiol. 7: 417.
- 4. CLSI. (2013) Performance Standards for Antimicrobial Susceptibility Testing Twenty-third Informational Supplement. In, vol. CLSI document M100-S23.
- 5. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM (2005) beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother. 56(1): 115-21.
- 6. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 10(4): 867-78.
- 7. Kilani H, Abbassi MS, Ferjani S, Mansouri R and Sghaier S et al. (2015) Occurrence of bla CTX-M-1, qnrB1 and virulence genes in avian ESBL-producing Escherichia coli isolates from Tunisia. Front Cell Infect Microbiol. 5:38.
- 8. Labro MT, Bryskier JM (2014) Antibacterial resistance: an emerging 'zoonosis'?Expert Rev Anti Infect Ther. 12(12):1441-61.
- 9. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM and van den Munckhof MP et al. (2011) Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect. 17(6):873-80.
- 10. Maamar E, Hammami S, Alonso CA, Dakhli N and Abbassi MS et al. (2016) High prevalence of extended-spectrum and plasmidic AmpC beta-lactamase-producing Escherichia coli from poultry in Tunisia.Int J Food Microbiol. 231:69-75.
- 11. Mahrouki S, Hammami S, Mansouri R, Abbassi M S. (2015) Overview of ESBL-producing Escherichia coli of Animal Origin in Tunisia: In the Way of the Global Spread of CTX-M β-Lactamases. Arch Clin Microbiol. 6(2): 4.
- 12. Michael R. Mulvey, Geoff Soule, David Boyd, Walter Demczuk, and Rafiq Ahmed (2003) Characterization of the First Extended-Spectrum Beta-Lactamase-Producing Salmonella Isolate Identified in Canada. J Clin Microbiol. 41(1): 460-62.
- 13. Ilse Overdevest, Ina Willemsen, Martine Rijnsburger, Andrew Eustace, Li Xu (2011) Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands. Emerg Infect Dis. 17(7): 1216-22.
- 14. Randall LP, Clouting C, Horton RA, Coldham NG and Wu G et al. (2011) Prevalence of Escherichia coli carrying extended-spectrum β-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009. J Antimicrob Chemother. 66(1): 86-95.
- 15. Randall LP, Lodge MP, Elviss NC, Lemma FL and Hopkins KL et al. (2017) Evaluation of meat, fruit and vegetables from retail stores in five United Kingdom regions as sources of extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Escherichia coli. Int J Food Microbiol. 241:283-290.